SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI)
CRIS 1.480-0.7%Oct 31 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg6/8/2007 4:05:27 PM
  Read Replies (1) of 668
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 6, 2007, the compensation committee (the "Compensation Committee") of the board of directors of Curis, Inc. (the "Company") determined the annual base salaries, effective as of June 6, 2007, of each named executive officer listed below, in the amounts listed below.

Named Executive Officer Annual Salary
Michael P. Gray, Chief Operating and Chief Financial Officer $ 300,000

Mark W. Noel, Vice President, Technology Management and Business
Development $ 210,000

Daniel R. Passeri, President and Chief Executive Officer $ 400,000

In addition, on June 6, 2007, the Compensation Committee determined the annual base salary, effective as of June 6, 2007, of Changgeng Qian, Ph.D., M.D., the Company's Vice President, Discovery and Preclinical Research, to be $235,000.

[Whatever happens with the company and its "products", these guys do well]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext